Are Pfizer’s COVID pills going to highest-risk patients? Inside the U.S. rollout

“If you just take the FDA at face value, you’re giving Paxlovid to an awful lot of people who will not benefit,” Dr. John Hick, an emergency physician at Hennepin County Medical Center in Minneapolis, said.